Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gastroenterology
•
Disorders of the Small Intestine
Do you feel there is a role for triple-phase budesonide in the management of patients with celiac disease who refuse to follow a gluten free diet?
How would you approach counseling the patient in this situation?
Related Questions
Is there a role for radiation in palliating malignant small bowel obstruction?
Do you discharge patients on preventative therapies like octreotide or bevacizumab after a patient's first admission for symptomatic anemia secondary to bleeding from a small bowel AVM that was treated with APC?
When and how do you do testing for disaccharidases on GI biopsies?
Do you prefer formal testing to establish a diagnosis of SIBO/IMO over empiric treatment?
How do you counsel a patient on returning to the care of their PCP when a workup for MCAS has been unrevealing, but the patient insists that they have a mast cell disorder because they respond to antihistamine therapy?
When and how should we use biomarkers (i.e., CRP, stool calprotectin, mAb levels) to guide or optimize medical management of Crohn’s disease or ulcerative colitis?
How do you approach the treatment of UC with PSC and how do you position oral vancomycin against biologic therapies?
When would you phlebotomize patients with secondary hemochromatosis, such as due to NAFLD/cirrhosis?
How would you manage a patient taking a GLP-1 agonist for weight loss who continues to have symptoms (i.e., nausea, vomiting) related to reduced GI motility despite dose adjustments?
Is there a role for anti-IL5 therapy in the treatment of EoE?